240 followers
RT @HealthEconBot: #HealthEconJA Cost Effectiveness of Secukinumab Versus Other Biologics and Apremilast in the Treatment of Active Psoriat…
RT @HealthEconBot: #HealthEconJA Cost Effectiveness of Secukinumab Versus Other Biologics and Apremilast in the Treatment of Active Psoriat…
#HealthEconJA Cost Effectiveness of Secukinumab Versus Other Biologics and Apremilast in the Treatment of Active Psoriatic Arthritis in Germany https://t.co/5HvoDNVt4O